Chemotherapy Induced Peripheral Neuropathy

Global Clinical Trials Review, H2, 2014

Published: Oct 2014

No. of Pages: 129

Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H2,

2014
Summary
GlobalData's clinical trial report, Chemotherapy Induced Peripheral
Neuropathy Global Clinical Trials Review, H2, 2014" provides data on the
Chemotherapy Induced Peripheral Neuropathy clinical trial scenario. This report
provides elemental information and data relating to the clinical trials on
Chemotherapy Induced Peripheral Neuropathy. It includes an overview of the
trial numbers and their recruitment status as per the site of trial conduction
across the globe. The databook offers a preliminary coverage of disease clinical
trials by their phase, trial status, prominence of the sponsors and also provides
briefing pertaining to the number of trials for the key drugs for treating
Chemotherapy Induced Peripheral Neuropathy. This report is built using data
and information sourced from proprietary databases, primary and secondary
research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and
Central America, Europe, Middle-East and Africa and Asia-pacific and top five
national contributions in each, along with the clinical trial scenario in BRIC
nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects
recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status,
recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals
or Companies

Detailed report at:

http://www.reportsandintelligence.com/chemotherapy-inducedperipheral-neuropathy-global-clinical-trials-review-h2-2014-market

Table of Content
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Chemotherapy Induced Peripheral Neuropathy 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Central and South America
14
Clinical Trials by G7 Countries: Proportion of Chemotherapy Induced Peripheral
Neuropathy to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Chemotherapy Induced Peripheral
Neuropathy to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24
Unaccomplished Trials of Chemotherapy Induced Peripheral Neuropathy 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Chemotherapy Induced Peripheral Neuropathy
Therapeutics Clinical Trials 30
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Pfizer Inc. 33
Clinical Trial Overview of Pfizer Inc. 33
Spectrum Pharmaceuticals, Inc. 34
Clinical Trial Overview of Spectrum Pharmaceuticals, Inc. 34
Sigma-Tau S.p.A. 35
Clinical Trial Overview of Sigma-Tau S.p.A. 35
Sanofi 36
Clinical Trial Overview of Sanofi 36
Immune Pharmaceuticals, Inc. 37
Clinical Trial Overview of Immune Pharmaceuticals, Inc. 37
DARA BioSciences, Inc. 38
Clinical Trial Overview of DARA BioSciences, Inc. 38
CK Life Sciences Int'l., (Holdings) Inc. 39
Clinical Trial Overview of CK Life Sciences Int'l., (Holdings) Inc. 39
CeNeRx BioPharma, Inc. 40
Clinical Trial Overview of CeNeRx BioPharma, Inc. 40
Ajanta Pharma Limited 41
Clinical Trial Overview of Ajanta Pharma Limited 41
Clinical Trial Overview of Top Institutes / Government 42
University of Texas M. D. Anderson Cancer Center 42
Clinical Trial Overview of University of Texas M. D. Anderson Cancer Center 42
North Central Cancer Treatment Group 43
Clinical Trial Overview of North Central Cancer Treatment Group 43
Mayo Clinic 44
Clinical Trial Overview of Mayo Clinic 44
Meiwa Hospital 45
Clinical Trial Overview of Meiwa Hospital 45
The Gynecologic Oncology Group 46
Clinical Trial Overview of The Gynecologic Oncology Group 46

Northwestern University 47
Clinical Trial Overview of Northwestern University 47
New Mexico Cancer Care Alliance 48
Clinical Trial Overview of New Mexico Cancer Care Alliance 48
Columbia University 49
Clinical Trial Overview of Columbia University 49
Legacy Health System 50
Clinical Trial Overview of Legacy Health System 50
University of Sao Paulo 51
Clinical Trial Overview of University of Sao Paulo 51
Five Key Clinical Profiles 52
Appendix 127
Abbreviations 127
Definitions 127
Research Methodology 128
Secondary Research 128
About GlobalData 128
Contact Us 128
Disclaimer 129
Source 129

Get detailed TOC at:

http://www.reportsandintelligence.com/chemotherapy-inducedperipheral-neuropathy-global-clinical-trials-review-h2-2014market/table-of-contents

Contact Us:
Deep Joshi
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
Direct: +1 (617) 674-4143
Toll Free: +1 (855) 711-1555
Fax: +1 (855) 550-5975
Email us: help@reportsandintelligence.com
Web: http://www.reportsandintelligence.com
Facebook: https://www.facebook.com/reportsnintelligence